Figuring out what the ultimate โLab 4.0โ looks like is a tough task, but to be successful in your digital journey, it is important to focus on your goals as a business, and what suits objectives and your staff most. Different methods will suit different organisations โ perhaps certain tasks must remain manual for your scientists to be efficient, while others are in dire need of digitalisation to drive efficiency and save lead time and costs. The question of finding a balance remains: will the lab of the future be fully automated, or is there a risk of creating complexity? Join our round-up panel discussion to hear what lab leaders wish to focus on going forward.
As a key element of the SDPR rollout, New South Wales Health Pathologyโs are implementing a single Lab Information Management System (LIMS). The project aims to enhance patient safety, quality, access, and equity while rethinking how pathology services are to delivered long-term. By centralising manual processes and data, NSW Pathology aims to reduce manual processing and inform and support cross functional data sharing.
Digital innovation offers opportunities for new data-driven insights, products and services that can assist laboratories, including those involved in biotech and biopharmaceutical development. In this talk, Sally will discuss how AI and machine learning can be used, drawing on practical examples from The ARC Digital Bioprocess Development Hub. Sally will outline how experimental data can help to train new models to increase yield, reduce experimental time and potentially increase product stability, as well the barriers to deployment of these models and governance considerations. The need for increased digital literacy and opportunities for upskilling the Australian workforce will also be discussed.
Exploring the challenges and opportunities faced by healthcare startups in translating scientific or technological innovations into market-ready solutions.